The drug development pipeline is bursting with new pharmaceutical products that may one day be useful in glaucoma therapy.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Moorfields, Topcon, IoO announce partnership launch of Cascader
Utilizing artificial intelligence (AI), Cascader is a new medical technology company that aims to transform the detection and management of eye disease.
Higher Molar Dose and Its Translation into Clinical Practice
ZEISS debuts Research Data Platform, highlights Boehringer Ingelheim partnership
Carl Zeiss Meditec plans to launch the ZEISS RDP in select countries throughout 2025
LuxIA receives CE-MDR certification
LuxIA is designed to screen adult diabetic patients for more-than-mild diabetic retinopathy.
EMA CHMP adopts positive opinion for teprotumumab (Tepezza, Amgen) marketing authorisation application
In the weeks to come, the European Commission will issue a decision on the first severe thyroid eye disease treatment
The future of microbial keratitis treatment is bright
Ultraviolet light’s potential in ocular care extends beyond structural reinforcement to antimicrobial applications, especially for microbial keratitis